Am J Transplant, Volume 16, Suppl 3 Archives - Page 49 of 180 - ATC Abstracts

2016 American Transplant Congress
A Model to Explore the Potential Budget Impact of a Novel Screening Tool for the Detection of Subclinical Rejection Among Kidney Transplant Patients.
K. Jaglinski,¹ H. Uchida,¹ T. Inocencio,² K. Hughes.²
¹Immucor, Inc, Waukesha, WI; ²Avalare Health, LLC, Washington, DC.
Background: Acute rejection among kidney transplant patients is common, with ~10% of individuals experiencing acute rejection within the first year and rising to 16-17% at…
2016 American Transplant Congress
Use of En-Bloc Vascularized Rectus Sheath Allograft to Achieve Abdominal Closure in Pediatric Liver and Multivisceral Transplantation.
J. Reddy, A. Rege, D. Vikraman, B. Collins, T. Brennan, S. Knechtle, D. Sudan, K. Ravindra.
Surgery, Duke University, Durham, NC.
Background: Abdominal wall closure is often challenging in pediatric liver (LT) and multivisceral transplantation (MVT) due to size discrepancy of donor & recipient and abdominal…
2016 American Transplant Congress
Biopsy-Proven Rejection in Children After Liver Transplantation Is Associated by an IL-12p40-Mediated Innate Immune Response Followed by Th1 T Cell Activation.
C. Falk,¹ I. Goldschmidt,² F. Mutschler,² E. Pfister,² F. Lehner,³ J. Keil,¹ C. Neudörfl,¹ A. Karch,⁴ R. Mikolajczyk,⁴ U. Baumann.²
¹Institute of Transplant Immunology, IFB-Tx, Hannover Medical School, Hannover, Bitte Wählen, Germany; ²Department of Pediatric Hepatology, Hannover Medical School, Hannover, Bitte Wählen, Germany; ³Department of Abdominal and Transplantation Surgery, Hannover Medical School, Hannover, Bitte Wählen, Germany; ⁴Department of Epidemiology, Helmholtz Center for Infection Research, HZI, Braunschweig, Germany.
Sustained by adaptive immune cells and their soluble mediators is well established for infection but it has not been demonstrated for solid organ transplantation in…
2016 American Transplant Congress
Factors Associated with Response to Plasmapheresis in Patients with Recurrent FSGS.
J. Shoji,¹ V. Tatapudi,² Z. Laszik,¹ A. Jones,³ J. Wolf,⁴ D. Adey,¹ F. Vincenti.¹
¹Department of Medicine, Division of Nephrology, University of California-San Francisco, California, CA; ²Department of Medicine, Division of Nephrology, New York University, New York, NY; ³Department of Sociology, George Washington University, Washington, DC; ⁴Transplant Surgery, Piedmont Transplant Institute, Atlanta, GA.
Background:Idiopathic focal segmental glomerulosclerosis (FSGS) is one of the primary glomerular diseases that commonly recurs in renal allograft and is known to be associated with…
2016 American Transplant Congress
Risk of Peritoneal Dialysis Catheter-Associated Peritonitis Following Kidney Transplant.
A. Rizzi,¹ S. Ruitta,¹ J. Peterson,¹ G. Gagin,¹ D. Fritze,¹ R. Sung,¹ Y. Lu,² K. Woodside.¹
¹Department of Surgery, University of Michigan, Ann Arbor, MI; ²Department of Internal Medicine, University of Michigan, Ann Arbor, MI.
While peritoneal dialysis (PD) has become more common, PD catheter management at the time of kidney transplant varies widely by transplant center. We sought to…
2016 American Transplant Congress
Concomitant Proton Pump Inhibitor and Mycophenolate Mofetil Use in Renal Transplant Recipients.
K. Patel,¹ B. Stephany,² J. Barnes,¹ S. Bauer,¹ M. Spinner.¹
¹Department of Pharmacy, Cleveland Clinic, Cleveland, OH; ²Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland, OH.
Pharmacokinetic (PK) data show reduced mycophenolic acid levels in transplant recipients taking mycophenolate mofetil (MMF) and proton pump inhibitors (PPIs) concomitantly. MMF dosing is not…
2016 American Transplant Congress
American and European Transplant Surgeons: Research, Teaching, and Burnout.
M. Jesse,¹ M. Abouljoud,¹ A. Eshelman,¹ C. DeReyck,² J. Lerut.²
¹Transplant Institute, Henry Ford Health System, Detroit, MI; ²Cliniques Universitaires, Saint-Luc, Bruxelles, Belgium.
Purpose: Examine whether location or research/teaching demands impacts burnout (emotional exhaustion, depersonalization, personal accomplishment).Method: Cross-sectional survey of American (US) and European (EU) organ transplant surgeons.Results:…
2016 American Transplant Congress
Liver Transplantation (LT) Using Liver Allografts from Deceased After Cardiac Death (DCD) Donors: Opinions, Practices and Reality.
L. Sher,¹ P. Abt,² Y. Genyk,¹ M. Lo,¹ P. Yan,¹ L. Ji,¹ C. Marsh.³
¹Keck Hospital/University of Southern California, Los Angeles; ²Hospital of the University of Pennsylvania, Philadelphia; ³Scripps Clinic & Green Hospital, San Diego.
Background: Scientific Studies Committee of ASTS conducted study to identify barriers to use of DCD liver grafts.Objectives: Identify barriers to use of DCD liver allografts;…
2016 American Transplant Congress
A New Diagnostic Score for Microvascular Inflammation in Antibody-Mediated Rejection in Heart Transplantation.
M. Racapé,¹ A. Loupy,² R. Guillemain,¹ A. François,³ P. Rouvier,⁴ C. Toquet,⁵ X. Jouven,¹ J. Venner,⁶ L. Hidalgo,⁶ J. Reeve,⁶ P. Bruneval,¹ J. Duong Van Huyen,² P. Halloran.²
¹European Georges Pompidou Hospital, Paris, France; ²Necker Hospital, Paris, France; ³Rouen University Hospital, Rouen, France; ⁴La Pitié Salpêtrière Hospital, Paris, France; ⁵Laennec Hospital, Nantes, France; ⁶University of Alberta, Edmonton, Canada.
BackgroundThe ISHLT working formulation defines Intravascular Activated Mononuclear Cells (IAMC) as one of the histopathologic features of antibody-mediated rejection (ABMR) in heart transplantation. However, no…
2016 American Transplant Congress
Ex Situ Perfusion of a Human Limb for 24 Hours.
N. Werner,¹ F. Alghanem,¹ S. Rakestraw,¹ B. Nicely,² A. Olszewksi,² S. Rudich,² A. Rojas-Pena,¹ J. Magee,¹ K. Ozer.³
¹Transplant Surgery, University of Michigan, Ann Arbor, MI; ²Gift of Life Michigan, Ann Arbor, MI; ³Orthopedic Surgery, University of Michigan, Ann Arbor, MI.
Background: Vascularized composite tissue (limb) allografts are procured and cold stored (4[deg]C) until surgery. This process is time limited as the tissue has to be…